Picture of Gubra A/S logo

GUBRA Gubra A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapContrarian

Brief: Partner Advances Gubra Originated Obesity Triple Agonist Peptide Into Phase 2

April 28 (Reuters) - Gubra A/S GUBRA.CO:

BOEHRINGER INGELHEIM ADVANCES GUBRA ORIGINATED OBESITY TRIPLE AGONIST PEPTIDE INTO PHASE 2 DEVELOPMENT

Source text: ID:nMFN7CfVNK

Further company coverage: GUBRA.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Gubra A/S

See all news